A

Amphastar Pharmaceuticals
D

AMPH

45.430
USD
0.87
(1.95%)
Market Closed
Volume
17,064
EPS
0
Div Yield
-
P/E
15
Market Cap
2,184,339,501
OverviewSignalsIdeasNews
Related Instruments
    A
    AAL
    0.120
    (0.84%)
    14.400 USD
    A
    AIT
    -4.57
    (-1.68%)
    266.71 USD
    A
    ALK
    1.080
    (2.04%)
    53.960 USD
    BA
    BA
    2.055
    (1.49%)
    149.28 USD
    DAL
    DAL
    -0.810
    (-1.25%)
    64.040 USD
    HEI
    HEI
    -6.64
    (-2.40%)
    270.40 USD
    L
    LUV
    0.190
    (0.59%)
    32.605 USD
    S
    SAVE
    -0.24000
    (-18.18%)
    1.08000 USD
    TDG
    TDG
    -19.06
    (-1.50%)
    1,254.10 USD
    U
    UAL
    0.010
    (0.01%)
    91.170 USD
    More
News

Title: Amphastar Pharmaceuticals

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has tworeportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.